Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 8C1V | 8C1V | SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map | |
| 8C2R | 8C2R | SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody | |
| 8C3V | 8C3V | SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody | |
| 8C7H | 8C7H | Cryo-EM Map of the latTGF-beta 28G11 Fab complex | |
| 8C7M | 8C7M | Interleukin 12 receptor subunit beta-1 Fn domains in complex with antagonistic FAb fragment. | |
| 8C89 | 8C89 | SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of RBD and Fab) | |
| 8C8T | 8C8T | cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with bNAbs EPTC112 and 3BNC117 | |
| 8C9X | 8C9X | human alpha7 nicotinic receptor in complex with the C4 nanobody | |
| 8CA9 | 8CA9 | Cryo-EM structure of the Cibeles-Demetra 3:3 heterocomplex from Galleria mellonella saliva | |
| 8CAU | 8CAU | human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine | |
| 8CBD | 8CBD | SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs | |
| 8CBE | 8CBE | SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs | |
| 8CBF | 8CBF | SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs | |
| 8CE4 | 8CE4 | Human alpha7 nicotinic receptor in complex with the E3 nanobody | |
| 8CF6 | 8CF6 | Dimethylated RSL-R5 in complex with cucurbit[7]uril, F432 cage assembly | |
| 8CH1 | 8CH1 | PBP AccA from A. vitis S4 in complex with Agrocinopine A | |
| 8CH2 | 8CH2 | PBP AccA from A. vitis S4 in complex with L-arabinose-2-phosphate (A2P) | |
| 8CH3 | 8CH3 | PBP AccA from A. vitis S4 in complex with Agrocinopine C-like | |
| 8CI1 | 8CI1 | Human alpha7 nicotinic receptor in complex with the E3 nanobody and nicotine | |
| 8CI2 | 8CI2 | human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions | |
| 8CII | 8CII | Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody | |
| 8CIM | 8CIM | BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN | |
| 8CIN | 8CIN | BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN | |
| 8CMA | 8CMA | SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab | |
| 8CML | 8CML | Cryo-EM structure of complement C5 in complex with nanobodies UNbC5-1 and UNbC5-2 | |
| 8CMO | 8CMO | Cryo-EM structure of the Photosystem I - LHCI supercomplex from Coelastrella sp. | |
| 8CN9 | 8CN9 | Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII | |
| 8COE | 8COE | complement C5 in complex with the LCP0195 nanobody | |
| 8COY | 8COY | Structure of the catalytic domain of P. vivax Sub1 (triclinic crystal form) in complex with inhibitor | |
| 8CSJ | 8CSJ | Cryo-EM structure of NTD-directed non-neutralizing antibody 4-33 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 8CT6 | 8CT6 | 1F8 mAb in complex with the computationally optimized broadly reactive H1 influenza hemagglutinin P1 | |
| 8CW9 | 8CW9 | Prefusion-stabilized hMPV fusion protein bound to ADI-61026 and MPE8 Fabs | |
| 8CWI | 8CWI | Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD) | |
| 8CWJ | 8CWJ | Fab arms of antibodies 4C12-B12 and CR3022 bound to pangolin receptor binding domain (pRBD) | |
| 8CWK | 8CWK | Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) | |
| 8CWU | 8CWU | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21 | |
| 8CWV | 8CWV | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab | |
| 8CXI | 8CXI | Structures of Zika Virus in Complex with Antibodies Targeting E Dimer Epitopes and Basis for Neutralization Efficacy | |
| 8CXN | 8CXN | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 | |
| 8CY7 | 8CY7 | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 | |
| 8CYA | 8CYA | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 | |
| 8CYB | 8CYB | SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 | |
| 8CYH | 8CYH | Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics | |
| 8CZZ | 8CZZ | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with Temsavir, 8ANC195, and 10-1074 | |
| 8D0Y | 8D0Y | Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom | |
| 8D0Z | 8D0Z | S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) | |
| 8D21 | 8D21 | Cryo-EM structure of the VRC321 clinical trial, vaccine-elicited, human antibody 1B06 in complex with a stabilized NC99 HA trimer | |
| 8D2S | 8D2S | Zebrafish MFSD2A isoform B in inward open ligand bound conformation | |
| 8D2T | 8D2T | Zebrafish MFSD2A isoform B in inward open ligand-free conformation | |
| 8D2U | 8D2U | Zebrafish MFSD2A isoform B in inward open ligand 1A conformation |
